Singapore Updates Guidance On Labeling, Essential Principles, Change Notification And Registration
Executive Summary
Singapore has issued new guidance in four important areas of medical device regulation. The documents don't include mandates, but are intended as references for the industry and are subject to continual revision when appropriate.
You may also be interested in...
Singapore Improves Time To Market For Lower-Risk Devices
The Singapore Health Sciences Authority says regulatory changes that will provide faster market access for class A and many class B devices kicked in on June 1. The requirements for telehealth devices and high-risk devices cosmetic devices have also been clarified.
Next ASEAN Device Committee Meeting Looms, But National Regs Top Priorities
New medtech regulations in Singapore, a new medtech law in the Philippines, and another deferral of Act 737 in Malaysia were the focus of the Asian Medtech Associations Regulatory Networking discussions this month. In a break from the usual focus, there was also an update on the EU MDR and preparations for Brexit from the UK Association of HealthTech Industries (ABHI). This series is hosted by Medtech Insight and sponsored by the Asia Regulatory and Quality Consultancy (ARQon), and the Asia Regulatory Professionals Association (ARPA).
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.